Piper Sandler Expands Healthcare Investment Banking Team with the Addition of Christian Draisbach
Piper Sandler Companies (NYSE: PIPR) has announced the appointment of Christian Draisbach as managing director to their healthcare investment banking team. Draisbach, who joins from Centerview Partners, brings 20 years of experience in advising biopharma executives and boards on strategic initiatives, mergers, acquisitions, divestitures, and partnership transactions across the U.S., Europe, and Asia.
Previously at Morgan Stanley in mergers and acquisitions and financial sponsor coverage groups, Draisbach holds an M.Sc. in finance from the London School of Economics and a B.A. from the University of St. Gallen. He will focus on advising and supporting clients in the biopharma sector, leveraging his experience that spans from early development-stage private transactions to major public deals.
Piper Sandler Companies (NYSE: PIPR) ha annunciato la nomina di Christian Draisbach come direttore generale del loro team di investment banking nel settore sanitario. Draisbach, che proviene da Centerview Partners, porta con sé 20 anni di esperienza nell'assistenza a dirigenti e consigli di amministrazione nel settore biopharma su iniziative strategiche, fusioni, acquisizioni, disinvestimenti e transazioni di partnership negli Stati Uniti, in Europa e in Asia.
In precedenza, Draisbach ha lavorato presso Morgan Stanley nei gruppi di fusioni e acquisizioni e copertura di sponsor finanziari. Ha conseguito un M.Sc. in finanza presso la London School of Economics e una laurea B.A. presso l'Università di San Gallo. Si concentrerà sull'assistenza e sul supporto ai clienti nel settore biopharma, sfruttando la sua esperienza che spazia da transazioni private in fase di sviluppo iniziale a importanti affari pubblici.
Piper Sandler Companies (NYSE: PIPR) ha anunciado el nombramiento de Christian Draisbach como director general de su equipo de banca de inversión en el sector salud. Draisbach, quien se une desde Centerview Partners, aporta 20 años de experiencia asesorando a ejecutivos y juntas directivas de biopharma en iniciativas estratégicas, fusiones, adquisiciones, desinversiones y transacciones de asociación en EE.UU., Europa y Asia.
Anteriormente en Morgan Stanley en los grupos de fusiones y adquisiciones y cobertura de patrocinadores financieros, Draisbach tiene una Maestría en Ciencias en finanzas de la London School of Economics y una licenciatura de la Universidad de San Gallen. Se centrará en asesorar y apoyar a los clientes en el sector biopharma, aprovechando su experiencia que abarca desde transacciones privadas en etapas de desarrollo inicial hasta importantes acuerdos públicos.
파이퍼 샌들러 컴퍼니즈 (NYSE: PIPR)는 크리스찬 드라이스바흐를 헬스케어 투자은행 팀의 전무 이사로 임명했다고 발표했습니다. 드라이스바흐는 센트뷰 파트너스에서 이전에 근무했으며, 미국, 유럽, 아시아 전역의 바이오제약 경영진과 이사회에 전략적 이니셔티브, 인수합병, 매각 및 파트너십 거래에 대한 자문을 제공한 20년의 경험을 보유하고 있습니다.
이전에는 모건 스탠리에서 인수합병 및 재정 후원자 커버리지 그룹에서 근무했으며, 런던 정치경제대학에서 금융학 석사 학위를, 생갈렌 대학교에서 학사 학위를 받았습니다. 그는 초기 개발 단계의 사적 거래부터 주요 공개 거래에 이르기까지 바이오제약 부문 고객을 자문하고 지원하는 데 집중할 것입니다.
Piper Sandler Companies (NYSE: PIPR) a annoncé la nomination de Christian Draisbach en tant que directeur général de son équipe de banque d'investissement dans le secteur de la santé. Draisbach, qui rejoint l'entreprise en provenance de Centerview Partners, apporte 20 ans d'expérience dans le conseil aux dirigeants et conseils d'administration des entreprises biopharmaceutiques sur des initiatives stratégiques, des fusions, des acquisitions, des cessions et des transactions de partenariat aux États-Unis, en Europe et en Asie.
Auparavant, Draisbach a travaillé chez Morgan Stanley dans les groupes de fusions et acquisitions et de couverture des sponsors financiers. Il est titulaire d'un M.Sc. en finance de la London School of Economics et d'une licence de l'Université de Saint-Gall. Il se concentrera sur le conseil et le soutien aux clients du secteur biopharmaceutique, s'appuyant sur son expérience qui va des transactions privées en phase de développement précoce à des affaires publiques majeures.
Piper Sandler Companies (NYSE: PIPR) hat die Ernennung von Christian Draisbach zum Managing Director ihres Healthcare-Investmentbanking-Teams bekannt gegeben. Draisbach, der von Centerview Partners kommt, bringt 20 Jahre Erfahrung in der Beratung von Führungskräften und Vorständen in der Biopharma-Branche zu strategischen Initiativen, Fusionen, Übernahmen, Veräußerungen und Partnerschaftstransaktionen in den USA, Europa und Asien mit.
Zuvor war Draisbach bei Morgan Stanley in den Bereichen Fusionen und Übernahmen sowie Finanzsponsor-Deckung tätig und hat einen M.Sc. in Finanzen von der London School of Economics sowie einen B.A. von der Universität St. Gallen. Er wird sich darauf konzentrieren, Kunden im Biopharma-Sektor zu beraten und zu unterstützen, wobei er auf seine Erfahrung zurückgreift, die von frühen Entwicklungsphasen privater Transaktionen bis hin zu bedeutenden öffentlichen Geschäften reicht.
- Strategic hire strengthens biopharma M&A capabilities
- Expansion of international presence in healthcare investment banking
- Addition of senior executive with extensive transaction experience
- None.
“We are excited for Christian to join our healthcare investment banking team. Christian brings 20 years of experience advising biopharma executives and boards through the lifecycle of their business on complex strategic initiatives and mergers, acquisitions, divestitures and partnership transactions in the
Draisbach joins the firm from Centerview Partners where he was a managing director primarily focused on clients in the life sciences and broader healthcare sectors. Earlier in his career, Mr. Draisbach worked at Morgan Stanley in the mergers and acquisitions and financial sponsor coverage groups based in the
“Piper Sandler has a well-earned reputation as a leading investment banking advisory firm in the healthcare sector and I’m excited to join at this pivotal inflection point in its growth strategy. Being at the forefront of providing intellectually rigorous and independent strategic advice, the firm has a long track record of building some of the most successful client-centric practices anchored in deep industry expertise. I look forward to working alongside this talented team and to build on its success serving clients in the biopharma sector in the
ABOUT PIPER SANDLER
Piper Sandler Companies (NYSE: PIPR) is a leading investment bank driven to help clients Realize the Power of Partnership®. Securities brokerage and investment banking services are offered in the
Follow Piper Sandler: LinkedIn | Facebook | X
©2025. Since 1895. Piper Sandler Companies. 800 Nicollet Mall,
View source version on businesswire.com: https://www.businesswire.com/news/home/20250407176429/en/
Piper Sandler Companies
800 Nicollet Mall, Suite 900
Nick Lawler
Tel: 212 891-8954
nick.lawler@psc.com
Source: Piper Sandler Companies
FAQ
What role has Christian Draisbach taken at Piper Sandler (PIPR)?
What experience does Christian Draisbach bring to Piper Sandler (PIPR)?
Where did Christian Draisbach work before joining Piper Sandler (PIPR)?
How will Draisbach's appointment impact Piper Sandler's (PIPR) biopharma business?
